Direkt zum Inhalt
Merck

Patterns of genome evolution that have accompanied host adaptation in Salmonella.

Proceedings of the National Academy of Sciences of the United States of America (2014-12-24)
Gemma C Langridge, Maria Fookes, Thomas R Connor, Theresa Feltwell, Nicholas Feasey, Bryony N Parsons, Helena M B Seth-Smith, Lars Barquist, Anna Stedman, Tom Humphrey, Paul Wigley, Sarah E Peters, Duncan J Maskell, Jukka Corander, Jose A Chabalgoity, Paul Barrow, Julian Parkhill, Gordon Dougan, Nicholas R Thomson
ZUSAMMENFASSUNG

Many bacterial pathogens are specialized, infecting one or few hosts, and this is often associated with more acute disease presentation. Specific genomes show markers of this specialization, which often reflect a balance between gene acquisition and functional gene loss. Within Salmonella enterica subspecies enterica, a single lineage exists that includes human and animal pathogens adapted to cause infection in different hosts, including S. enterica serovar Enteritidis (multiple hosts), S. Gallinarum (birds), and S. Dublin (cattle). This provides an excellent evolutionary context in which differences between these pathogen genomes can be related to host range. Genome sequences were obtained from ∼ 60 isolates selected to represent the known diversity of this lineage. Examination and comparison of the clades within the phylogeny of this lineage revealed signs of host restriction as well as evolutionary events that mark a path to host generalism. We have identified the nature and order of events for both evolutionary trajectories. The impact of functional gene loss was predicted based upon position within metabolic pathways and confirmed with phenotyping assays. The structure of S. Enteritidis is more complex than previously known, as a second clade of S. Enteritidis was revealed that is distinct from those commonly seen to cause disease in humans or animals, and that is more closely related to S. Gallinarum. Isolates from this second clade were tested in a chick model of infection and exhibited a reduced colonization phenotype, which we postulate represents an intermediate stage in pathogen-host adaptation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Propylenglycol, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
Ethanolamin, ≥99%
Sigma-Aldrich
Ethanolamin, purified by redistillation, ≥99.5%
USP
Propylenglycol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ethanolamin, ≥98%
Sigma-Aldrich
1,2-Propandiol, ACS reagent, ≥99.5%
Sigma-Aldrich
Propylenglykol, meets USP testing specifications
Sigma-Aldrich
Ethanolamin, ACS reagent, ≥99.0%
Supelco
Propylenglykol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
1,2-Propandiol, ReagentPlus®, 99%
Sigma-Aldrich
Ethanolamin, liquid, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
1,2-Propandiol, puriss. p.a., ACS reagent, ≥99.5% (GC)
Supelco
1,2-Propandiol, analytical standard
Sigma-Aldrich
1,2-Propandiol, meets analytical specification of Ph. Eur., BP, USP, ≥99.5%
Supelco
Ethanolamin, analytical standard
Propylenglycol, European Pharmacopoeia (EP) Reference Standard
Supelco
Aucubin, analytical standard
Sigma-Aldrich
Ethanolamin, puriss. p.a., ACS reagent, ≥99.0% (GC/NT)
Sigma-Aldrich
1,2-Propandiol, tested according to Ph. Eur.
Trolamin Unreinheit A, European Pharmacopoeia (EP) Reference Standard
Aucubin, primary reference standard